BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14724108)

  • 21. [A case of hepatosplenic gammadelta T cell lymphoma].
    Wang FX; Zhang XJ; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant lymphoma without lymphadenopathy.
    Kini U; Alexander B; Correa M
    J Assoc Physicians India; 2008 May; 56():383-5. PubMed ID: 18700647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary sinusoidal lymphoma of the liver revealed by autoimmune hemolytic anemia.
    Pouderoux P; Gris JC; Pignodel C; Joujoux JM; Schved JF; Balmes JL
    Gastroenterol Clin Biol; 1997; 21(6-7):514-8. PubMed ID: 9295981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatosplenic gamma delta T-cell lymphoma with a novel cytogenetic alteration and cerebrospinal fluid infiltration: biological and clinical features.
    Ferrari D; Girmenia G; Migliorini L; Nosari A; Morra E
    Haematologica; 2002 Mar; 87(3):ECR11. PubMed ID: 11869957
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatosplenic T-cell lymphoma: sinusoidal localization of malignant T-cells--a case report.
    Kakkar N; Banerjee AK; Marwaha N; Deodhar SD
    Am J Hematol; 1996 Dec; 53(4):278-9. PubMed ID: 8948673
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
    Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
    Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
    Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
    Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules.
    Sadahira Y; Notohara K; Manabe T
    J Clin Pathol; 2003 Aug; 56(8):631-3. PubMed ID: 12890821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary peripheral T-cell lymphoma of the penis: a case report and review of the literature].
    Shi YL; Yin HL; Zhou XJ; Zhou HB; Lu ZF
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):1003-6. PubMed ID: 19102501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic study of hepatosplenic T-cell lymphoma].
    Zhang S; Nong L; Ren YL; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):387-91. PubMed ID: 18677385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
    Roelandt PR; Maertens J; Vandenberghe P; Verslype C; Roskams T; Aerts R; Nevens F; Dierickx D
    Liver Transpl; 2009 Jul; 15(7):686-92. PubMed ID: 19562701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
    Bennett M; Matutes E; Gaulard P
    Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatosplenic T-cell lymphoma: A case series.
    Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatosplenic γδ T-cell lymphoma: an overview.
    Visnyei K; Grossbard ML; Shapira I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.
    Weidmann E
    Leukemia; 2000 Jun; 14(6):991-7. PubMed ID: 10865963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematologic malignancies with extramedullary spread of disease. Case 2. Hepatosplenic T-cell lymphoma.
    Shahab N; Kissenger RL; Malhotra V; Doll DC
    J Clin Oncol; 2003 May; 21(9):1889-90. PubMed ID: 12721269
    [No Abstract]   [Full Text] [Related]  

  • 37. Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow.
    Ahmad E; Kingma DW; Jaffe ES; Schrager JA; Janik J; Wilson W; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2005 Sep; 67(1):6-12. PubMed ID: 15973700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
    Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
    Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
    Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
    Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapsed hepatosplenic T-cell lymphoma heralded by a solitary skin nodule.
    Hocker TL; Wada DA; McPhail ED; Porrata LF; el-Azhary RA; Gibson LE
    J Cutan Pathol; 2011 Nov; 38(11):899-904. PubMed ID: 21752051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.